In conclusion, dorzagliatin regulates glucose homeostasis not only via its dual-activating GK activities in the pancreas and liver but also through the improvement of glucose-stimulated GLP-1 release in T2D patients. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.